Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The clinical syndrome of PSP responds poorly to all available forms of therapy used in
Parkinson's Disease (PD). Currently, no effective treatment exists. Coenzyme Q10 in high
doses has been shown to be a beneficial therapy in PD and might possibly be a beneficial
therapy for PSP. This study will compare the efficacy, safety and tolerability of Coenzyme
Q10 versus placebo in patients with atypical parkinsonian syndrome, progressive supranuclear
palsy (PSP).